Prevention of Venous Thromboembolism - Prophylaxis with a low molecular weight heparin (Fragmin)

By Agnelli G.   Sonaglia F.  

Thrombosis Research, Vol. 97, Iss. 1, 2000-01 ,pp. : 49-62

Elsevier

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin Prophylaxis: Preoperative Versus Postoperative Initiation in Patients Undergoing Elective Hip Surgery

By Hull R.D.   Pineo G.F.   MacIsaac S.  

Thrombosis Research, Vol. 101, Iss. 1, 2001-01 ,pp. : 155-162

Elsevier

Access to resources Recommend Favorite

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement - results from Phase II studies

By Eriksson B.I.   Ogren M.   Eriksson U.G.   Kalebo P.   Ahnfelt L.   Bjorkstrom S.   Sjostedt .   Folestad A.   Arfwidsson A.-C.   Elvander C.S.   Frison L.  

Thrombosis Research, Vol. 105, Iss. 5, 2002-03 ,pp. : 371-378

Elsevier

Access to resources Recommend Favorite

For the Initial Treatment of Venous Thromboembolism - Are All Low-molecular-weight Heparin Compounds the Same?

By van der Heijden J.F.   Prins M.H.   Buller H.R.  

Thrombosis Research, Vol. 100, Iss. 2, 2000-10 ,pp. : 121-130

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

By Lee A.Y.Y.   Levine M.N.   Baker R.I.   for the Randomized Comparison of Low-Molecular-Weight Heparin vs. Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer CLOT Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 19-20

Elsevier

Access to resources Recommend Favorite